General Information of the Compound
| Compound ID |
CP0109190
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]-4-[5-(4-fluorophenyl)-1H-imidazol-2-yl]piperidine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H33F2N3O2
|
||||||||||||||||||
| Molecular Weight |
517.62
|
||||||||||||||||||
| Canonical SMILES |
CCOc1cc(CN2CCC(CC2)c2ncc([nH]2)-c2ccc(F)cc2)cc(OCC)c1-c1ccc(F)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H33F2N3O2/c1-3-37-28-17-21(18-29(38-4-2)30(28)23-7-11-26(33)12-8-23)20-36-15-13-24(14-16-36)31-34-19-27(35-31)22-5-9-25(32)10-6-22/h5-12,17-19,24H,3-4,13-16,20H2,1-2H3,(H,34,35)
Show/Hide
|
||||||||||||||||||
| InChIKey |
GOBNHYGEALNGCV-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01693, Somatostatin receptor type 3
Protein ID: PT06443, Somatostatin receptor type 5
Protein ID: PT01196, Somatostatin receptor type 5